Back to mobile site

Exact Sciences (EXAS) Tops Q3 EPS by 47c

November 1, 2023 4:12 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of $0.00, $0.47 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $628 million versus the consensus estimate of $616.79 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings